Based on the data showing that the absence of RGS6 decreased doxorubicin-induced myocardial cell apoptosis, the authors of that study concluded that RGS6 promotes doxorubicin-induced cardiomyopathy (41). Here, RGS6 is linked to cardiomyopathy.